Dr. Kocho Angjushev

private citizen

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.3M in lobbying spend across 5 quarterly filings, Dr. Kocho Angjushev is a significant lobbying presence. Their lobbying covers 1 issue area.

$1.3M
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$1.3M

Issues Lobbied

Trade

Lobbying Firms

Mercury Public Affairs, LLC

Lobbyists

Peter KucikBryan Lanza

Government Agencies Targeted

These are the government entities that Dr. Kocho Angjushev disclosed contacting in their lobbying filings.

Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESSENATEState, Dept of (DOS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade

Issues related to boa fide trade or commerce

issues related to BonaFide Trade and Commerce

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Meta Platforms, INC. and Various Subsidiaries
$168.9M total spend
Bayer Corporation (Consolidated Report)
$73.0M total spend
Shell USA, INC. (FKA Shell Oil Company)
$58.7M total spend
General Electric Company (Including Subsidiaries)
$49.6M total spend
GSK (FKA Glaxosmithkline INC.)
$39.9M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.